I heard this too, 2 per territory. Juluca way underperforming, competitors product performing much better than expected. The three of us in my pod just getting buried here. Hard for me to figure it out, especially the Triumeq/Tivicay switches. Crazy.
Above is true. We can reach and frequency all we want, the customers aren’t buying it. We got a huge dog in Juluca on our hands, and I fear what’s next will be just as bad.
Reach and Frequency is more of a job validator. Another words, HIV reps making 4 calls per day was easy when you were pretty much the only game in town. So you would make your calls from 10 - 2 and all was good. All things come to an end. R&F is only going to get worse. You need to show that you put in an honest days work. Sorry HIV, 50% cut. Those who stay can expect big brother to hound you every week. Welcome to big pharma.
Give us a decent drug to sell, and you won’t have to worry about reach and frequency. Dol/Rilp is a crap drug that no one is using, and no one ever will! It’s embarrassing going in even trying to peddle this snake oil.
The problem is, you folks are only making 4 calls per day. FOUR F-ING CALLS!!! Easy to cut that division by half and use R&F to have one rep average 7 calls per day. Doesn't take a genius to figure that out.
Need HIV TAMs to keep GSKs two biggest drugs from tanking. Smaller solo territories and fewer managers. No genius needed.
i heard it’s official, with latest Juluca numbers it appears downsizing happening in Q4. Not sure going to 2 reps per POD, or 1.5 reps per POD. Bigger focus on retaining existing business, not selling Juluca. Get your resume ready, it’s going to be a blood bath!
Thats fine. Bury your head in the sand. All 3 of us working these PODS are definitely generating enough Juluca prescriptions to justify our pay....Ha-ha.....
I work for Janssen. I Hear on a weekly basis the over abundance of VIIV reps coming into my customers offices. These reps are getting very pushy, almost desperate, selling a drug (Juluca) that none of my customers plan on ever using. There is no way GSK keeps the amount of HIV reps they have selling what they’ve got....NO WAY!
